🇺🇸 FDA

Drug profile · INN

desonide

DESOWEN

FDA: approved
US status
approved
Patents linked
5
News articles
0

Quick answer

desonide (DESOWEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN desonide
Brand DESOWEN
Route TOPICAL
Formulation AEROSOL, FOAM

Related patents

Search patents →

  1. US 11413296

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9119863

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8975243

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8497258

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8324192

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is desonide?

desonide (DESOWEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for desonide?

DESOWEN is a marketed brand name for desonide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of desonide?

desonide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.